logo Click here for the Chao Family Comprehensive Cancer Center Home Page Click here for the UC Irvine Home Page

Allen and Lee-Hwa Chao Lectureship in Cancer Research

The Cancer Center's premiere annual event, the Allen and Lee-Hwa Chao Lectureship in Cancer Research honors the late Hsi-Hsiung Chao by brining internationally renowned leaders in the field of cancer research to UC Irvine to share insight, provoke thought and stimulate conversation about the myriad issues surrounding cancer. Serving both the campus and the wider community, speakers present two lectures, one tailored to a general audience (the Community Lecture) and the other to a technical audience (the Scientific Lecture). Both lectures are free to attend, but registration is required.

The 2015-16 Chao Lectureship Presents:

Dr. Atul Butte photo

Dr. Atul Butte, MD, PhD

Director, Institute for Computational Health Sciences
Professor of Pediatrics
University of California, San Francisco

"Translating a trillion points of data into therapies, diagnostics, and new insights into disease"

Community Lecture

6:00 p.m., Tuesday, February 23, 2016
Beckman Center, UC Irvine Campus
100 Academy Drive, Irvine, CA
Pre-lecture reception at 5:00 p.m.

RSVP Required: Email ChaoLectureRSVP@uadv.uci.edu or call 714-456-5800 by February 12, 2016.

Scientific Lecture

12:30 p.m., Wednesday, February 24, 2016
110 Tamkin Hall, UC Irvine Campus

RSVP Required: Click here to RSVP for the Scientific Lecture. Deadline to RSVP is February 12, 2016.


There is an urgent need to take what we have learned in our new “genome era” and use it to create a new system of precision medicine, delivering the best preventative or therapeutic intervention at the right time, for the right patients. Dr. Butte's lab at the University of California, San Francisco builds and applies tools that convert trillions of points of molecular, clinical, and epidemiological data—measured by researchers and clinicians over the past decade and now commonly termed “big data”—into diagnostics, therapeutics, and new insights into disease. Dr. Butte, a computer scientist and pediatrician, will highlight how publicly-available molecular measurements can be used to find new uses for drugs including drugs for inflammatory bowel disease and cancer, discovering new diagnostics include blood tests for complications during pregnancy, and how the next generation of biotech companies might even start in your garage.

About the Speaker

Atul Butte, MD, PhD is the inaugural Director of the Institute of Computational Health Sciences (ICHS) at the University of California, San Francisco, and a Professor of Pediatrics. Dr. Butte is also the Executive Director for Clinical Informatics across the six University of California Medical Schools and Medical Centers. Dr. Butte trained in Computer Science at Brown University, worked as a software engineer at Apple and Microsoft, received his MD at Brown University, trained in Pediatrics and Pediatric Endocrinology at Children's Hospital Boston, then received his PhD from Harvard Medical School and MIT. Dr. Butte has authored nearly 200 publications, with research repeatedly featured in Wired Magazine, the New York Times, and the Wall Street Journal. In 2013, Dr. Butte was recognized by the White House as an Open Science Champion of Change for promoting science through publicly available data. Other recent awards include election into the Institute of Medicine in 2015 (now known as the National Academy of Medicine), the 2014 E. Mead Johnson Award for Research in Pediatrics, 2013 induction into the American Society for Clinical Investigation, the 2012 FierceBiotech IT “Top 10 Biotech Techies”, and the 2011 National Human Genome Research Institute Genomic Advance of the Month. Dr. Butte is also a founder of three investor-backed data-driven companies: Personalis, providing clinical interpretation of whole genome sequences, Carmenta (acquired by Pro genity), discovering diagnostics for pregnancy complications, and NuMedii, finding new uses for drugs through open molecular data. Dr. Butte is also the principal investigator of the California Initiative to Advance Precision Medicine, and the principal investigator for ImmPort, the clinical and molecular data repository for the National Institute of Allergy and Infectious Diseases.